Risk of COVID-19 and its complications in patients with atopic dermatitis undergoing dupilumab treatment—a population-based cohort study

Young HIV‐positive male patient with severe atopic dermatitis on dupilumab and SARS‐CoV‐2 infection, a pioneer hypothesis

(2021) María F. Ordóñez‐Rubiano et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology

(2020) Jasper C. A. Broen et al.   Nature Reviews Rheumatology

COVID‐19 in solid organ transplant recipients: A single‐center case series from Spain

(2020) Mario Fernández‐Ruiz et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Clinical outcome in solid organ transplant recipients with COVID‐19: A single‐center experience

(2020) Giovanna Travi et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

(2020) Milena Gianfrancesco et al.   ANNALS OF THE RHEUMATIC DISEASES

COVID-19 infection: the perspectives on immune responses

(2020) Yufang Shi et al.   CELL DEATH AND DIFFERENTIATION

Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry

(2020) Erica J. Brenner et al.   GASTROENTEROLOGY

COVID-19 in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab

(2020) Ulrike Förster-Ruhrmann et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19

(2020) Yang Yang et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Safety of dupilumab in atopic patients during COVID-19 outbreak

(2020) Maddalena Napolitano et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis

(2020) Zhaohai Zheng et al.   JOURNAL OF INFECTION

The impact of COPD and smoking history on the severity of COVID‐19: A systemic review and meta‐analysis

(2020) Qianwen Zhao et al.   JOURNAL OF MEDICAL VIROLOGY

SARS‐CoV‐2 asymptomatic infection in a patient under treatment with dupilumab

(2020) Francesca Caroppo et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Safety of dupilumab in severe atopic dermatitis and infection of Covid‐19: two case reports

(2020) S. Ferrucci et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-infection and atopic dermatitis

(2020) Andreas Wollenberg et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System

(2020) Vikas Mehta et al.   Cancer Discovery

Dupilumab, Severe Asthma Airway Responses, and SARS‐CoV2 Serology

(2020) Anurag Bhalla et al.   ALLERGY

Management of adult patients with severe atopic dermatitis treated with dupilumab during COVID ‐19 pandemic: A single‐center real‐life experience

(2020) Mariateresa Rossi et al.   Dermatologic Therapy

Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic

(2020) Donovan G. Kearns et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Cytokine release syndrome in COVID-19: Innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex

(2020) Aaron C. Petrey et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Immunosuppressive Drugs and COVID-19: A Review

(2020) Tessa S. Schoot et al.   Frontiers in Pharmacology

Human recombinant soluble ACE2 in severe COVID-19

(2020) Alexander Zoufaly et al.   Lancet Respiratory Medicine

Poor outcome of SARS-CoV-2 infection in patients with severe asthma on biologic therapy

(2020) Katrien Eger et al.   RESPIRATORY MEDICINE

Dupilumab maintenance therapy in an asthmatic patient with coronavirus disease 2019 pneumonia

(2020) Naoya Tanabe et al.   ALLERGOLOGY INTERNATIONAL

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

(2017) Andrew Blauvelt et al.   LANCET

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

(2016) Eric L. Simpson et al.   NEW ENGLAND JOURNAL OF MEDICINE